Tablets, Capsules, Liquids, Patches and Inhalers: Why Dosage Form Matters
A dosage form is the physical form in which a medicine is supplied, such as a tablet, liquid, cream, patch or inhaler. It is part of how the medicine reaches its intended site and how its strength is expressed. Two products can share an active ingredient yet require different technique, timing or safety checks because their forms or routes are different.
Key takeaways
- Dosage form and route are part of the medicine’s identity, not packaging preferences; they affect where and how the active ingredient is delivered.
- Strength is expressed differently across forms, for example per tablet, per measured volume, per actuation, per gram or over a patch’s labelled time.
- Do not crush, open, dissolve, split or substitute a dosage form without checking the product information and asking a pharmacist when uncertain.
What is the difference between dosage form and route?
The dosage form describes the finished product. The route of administration describes where or how it is used.
| Dosage form | Common route | Label detail that matters |
|---|---|---|
| Tablet or capsule | Oral | Strength per unit; standard or modified release; coating and split/open instructions |
| Oral solution or suspension | Oral | Concentration per measured volume; whether shaking or a measuring device is required |
| Cream, ointment or gel | Topical | Strength per gram or percentage; application site and whether skin must be intact |
| Patch | Transdermal or topical | Delivery or content statement, wear time and application instructions |
| Metered inhaler or dry-powder inhaler | Inhalation | Amount per actuation, device technique and dose counter |
| Eye or ear drops | Ophthalmic or otic | Correct body site, concentration, sterility and in-use period |
| Suppository | Rectal or vaginal, depending on product | Strength per unit and intended route |
The pair matters. “Solution” alone does not say whether a product is swallowed, inhaled, injected or used in an eye. A medicine name without route and form is therefore incomplete.
Regulators treat these as core product characteristics. The FDA requires a conventional generic to use the same dosage form and route as its reference medicine. Singapore HSA product records likewise display dosage form and route separately.
Are tablets and capsules interchangeable?
Not from appearance or ingredient alone. A standard tablet and a standard capsule may sometimes be authorised as alternatives, but that is a product-specific regulatory and clinical question. Their shell, excipients, dissolution and instructions can differ. A capsule may contain powder, liquid or specially coated pellets; a tablet may be uncoated, film-coated, chewable, dispersible, enteric-coated or designed to release medicine over time.
This is why “it is still oral” is not enough. The FDA’s Orange Book definitions classify different dosage forms as pharmaceutical alternatives rather than pharmaceutical equivalents. A pharmacist needs the exact products and prescription to decide what can replace what under local rules.
Physical needs also matter. A large tablet may be difficult to swallow, while a liquid may be easier to measure for some people but harder for someone with poor vision or hand control. Taste, portability, storage and the availability of an accurate measuring device can affect practical use. These are valid questions, but they do not justify altering a product at home.
What is different about oral liquids?
Oral liquids commonly state strength as a concentration, such as an amount in each 5 mL. The first number is not the volume to take; it is the amount of active ingredient in the stated volume. Two bottles can contain the same ingredient but different concentrations, so copying a volume from an old label can be dangerous.
Some liquids are solutions, in which the ingredient is dissolved. Others are suspensions, in which particles are dispersed and may settle; the label may instruct the user to shake before measuring. Some powders must be mixed to form a liquid, after which storage conditions and an in-use expiry may change.
Use the supplied or recommended oral syringe, cup or spoon when the directions call for one. Household spoons are not reliable measuring tools. If the concentration or device markings do not match the directions, obtain clarification rather than converting units independently.
Why do modified-release and enteric coatings matter?
Release design controls when or where a medicine becomes available. Modified-, sustained-, controlled- and extended-release products are designed to release the ingredient differently from an immediate-release form. Enteric coatings can delay release until after the tablet passes through the stomach.
Crushing or chewing can destroy that design. The Institute for Safe Medication Practices warns that crushing extended-release products can release a large amount too quickly, while crushing enteric-coated tablets removes their intended protection. NHS guidance similarly advises people not to crush tablets or open capsules without professional advice.
Abbreviations such as MR, SR, CR, ER, XR, XL and EC are clues, not a universal decoding system. Some products have special instructions without an obvious suffix. Check the product leaflet every time.
A score line also does not automatically mean a tablet can be divided into equal doses. HSA’s Singapore labelling guidance specifically distinguishes score lines used only to make swallowing easier from score lines intended to divide a tablet into equal halves.
What changes with creams, patches and inhalers?
Topical products are generally intended for a local application site, while a transdermal patch may be designed to deliver medicine through the skin over time. Similar-looking patches can have different wear periods, adhesion instructions, heat precautions and disposal requirements. Cutting a patch can alter delivery for some designs and should not be assumed acceptable.
Creams, ointments, lotions and gels can spread and absorb differently. The same percentage does not necessarily make two different forms directly substitutable, and “external use” directions matter around broken skin, eyes and mucous membranes.
Inhalers add a device to the formulation. A pressurised metered-dose inhaler, dry-powder inhaler and nebuliser solution can contain the same ingredient family but require different technique and strength interpretation. Products listed under salbutamol, budesonide or fluticasone should therefore be compared by device and presentation as well as ingredient. Poor technique can reduce delivery, so a device change deserves demonstration from a pharmacist or respiratory professional.
Eye drops, ear drops and nasal products make the route distinction especially visible: similar bottles do not make their contents interchangeable. Use only for the labelled site.
What changes the answer?
The best form depends on more than convenience. Swallowing ability, age, dexterity, vision, cognition, allergies, feeding tubes, the intended site of action and the need for a particular release pattern can all matter. Kidney or liver function, pregnancy and other medicines can change suitability but are not solved by choosing a different physical form.
Children’s products and concentrated liquids require particular attention to the complete strength expression and measuring device. Inhalers require enough inspiratory ability and correct technique for that device. Patches require suitable skin and adherence to heat and placement instructions. Feeding-tube administration has product-specific compatibility issues and needs professional guidance.
Availability also does not establish equivalence. If a preferred form is unavailable, ask the prescriber or pharmacist to assess an authorised alternative rather than improvising with the form on hand.
What should you check before changing form?
Bring the current pack or a clear photo of all label panels to the pharmacist. Identify the active ingredient, strength, dosage form, route, release wording, directions and reason a different form is being considered. Mention swallowing problems, allergies, feeding tubes, pregnancy and difficulties using a measuring device, patch or inhaler.
Do not convert between tablet and liquid strengths, transfer medicine to an unlabelled container, or manipulate tablets and capsules unless the specific product has been checked. Seek urgent help for signs of a serious allergic reaction, such as swelling of the face or throat or difficulty breathing, regardless of dosage form.
Catalogue ingredient pages can reveal available presentations, but the selected form must match the prescription and the user’s needs. The product leaflet and pharmacist remain the source for how that form is prepared and used.
Sources
- FDA: Dosage Forms.
- FDA: Generic Drugs Overview & Basics.
- HSA Singapore: Guidance documents for therapeutic products, including Appendix 7 labelling guidance.
- Institute for Safe Medication Practices: Crushing or splitting the wrong tablet can be a deadly error.
- NHS: Problems swallowing pills.
- HSA Singapore: Cough and cold medicines for children.
